Trial Profile

Phase 3 clinical study of Sarconeos

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 20 Feb 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sarconeos (Primary)
Indications Sarcopenia
Focus Registrational; Therapeutic Use
Acronyms SARA-31
Sponsors Biophytis

Most Recent Events

11 Feb 2025 According to a Biophytis media release, company plans to launch phase 3 of its SARA clinical program in the coming months.
22 Mar 2024 According to a Biophytis media release, company presented its phase 3 protocol at the International Conference on Frailty and Sarcopenia Research (ICFSR), held from March 20 to 22, 2024 in Albuquerque, NM, USA.
11 Sep 2023 According to a Biophytis media release, the effective start of the study is scheduled for 2024.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com